New Medicine Nirsevimab-alip for treatment and prevention of Respiratory Syncytial Virus
Nirsevimab-alip: A Potential Breakthrough in Preventing Respiratory Syncytial Virus (RSV) Infections USFDA approved new drug Beyfortus containing monoclonal antibodies Nirsevimab-alip…